Auto antibodies to GLDN have been detected in other chronic demyelinating conditions such as multiple sclerosis (MS) involving the CNS and in particular chronic inflammatory demyelinating polyradiculoneuropathy involving the peripheral nervous system (Kira et al., 2019). The gene discussed is GLDN; the disease is myeloid sarcoma.